Structure-based design of inhibitors of the zinc-dependent enzymes histone deacetylase (HDAC) and UDP-3-O-(R-3-hydroxymyristoylyl)-N-acetylglucosamine deacetylase (LpxC)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Halle (Saale), Martin-Luther-Universität Halle-Wittenberg, Dissertation, 2023
- Event
-
Veröffentlichung
- (where)
-
Halle (Saale)
- (who)
-
Universitäts- und Landesbibliothek Sachsen-Anhalt
- (when)
-
2023
- Creator
- Contributor
- DOI
-
10.25673/109902
- URN
-
urn:nbn:de:gbv:3:4-1981185920-1118579
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:46 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bülbül, Emre Fatih
- Sippl, Wolfgang
- Holl, Ralph
- Nicolaes, Gerry
- Universitäts- und Landesbibliothek Sachsen-Anhalt
Time of origin
- 2023
Other Objects (12)
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs
The histone deacetylase (HDAC) Rpd3 antagonizes heterochromatin formation at telomeres in Saccharomyces cerevisiae
Balancing Histone Deacetylase (HDAC) Inhibition and Druglikeness : Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
Targeting aberrant histone acetylation in cancer: development of class I selective histone deacetylase (HDAC) inhibitors and dual HDAC/BET bromodomain inhibitors
Development of class IIa histone deacetylase inhibitors
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Selectivity in histone deacetylase inhibition: A biophysical approach
Histone deacetylase inhibitors regulate the proteasomal degradation of oncoproteins
Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs
The histone deacetylase (HDAC) Rpd3 antagonizes heterochromatin formation at telomeres in Saccharomyces cerevisiae
Balancing Histone Deacetylase (HDAC) Inhibition and Druglikeness : Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
Targeting aberrant histone acetylation in cancer: development of class I selective histone deacetylase (HDAC) inhibitors and dual HDAC/BET bromodomain inhibitors
Development of class IIa histone deacetylase inhibitors
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Selectivity in histone deacetylase inhibition: A biophysical approach
Histone deacetylase inhibitors regulate the proteasomal degradation of oncoproteins
Histone deacetylase inhibition sensitizes osteosarcoma to heavy ion radiotherapy
The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs
The histone deacetylase (HDAC) Rpd3 antagonizes heterochromatin formation at telomeres in Saccharomyces cerevisiae
Balancing Histone Deacetylase (HDAC) Inhibition and Druglikeness : Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
Targeting aberrant histone acetylation in cancer: development of class I selective histone deacetylase (HDAC) inhibitors and dual HDAC/BET bromodomain inhibitors
Development of class IIa histone deacetylase inhibitors
Regulatory mechanisms of histone deacetylase 2 Sumoylation
Role of histone deacetylase 11 in neuroblastoma
Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
Histone deacetylase inhibitor valproic acid in pancreas differentiation
Selectivity in histone deacetylase inhibition: A biophysical approach
Histone deacetylase inhibitors regulate the proteasomal degradation of oncoproteins